dc.contributor.author |
Vuong, L.N. |
|
dc.contributor.author |
Le, A.H. |
|
dc.contributor.author |
Ho, V.N.A. |
|
dc.contributor.author |
Pham, T.D. |
|
dc.contributor.author |
Sanchez, Flor |
|
dc.contributor.author |
Romero Loyola, Sergio Jean Markos |
|
dc.contributor.author |
De Vos, M. |
|
dc.contributor.author |
Ho, T.M. |
|
dc.contributor.author |
Gilchrist, R.B. |
|
dc.contributor.author |
Smitz, J. |
|
dc.date.accessioned |
2020-12-14T16:11:08Z |
|
dc.date.available |
2020-12-14T16:11:08Z |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/8852 |
|
dc.description.abstract |
Purpose: Standard oocyte in vitro maturation (IVM) usually results in lower pregnancy rates than in vitro fertilization (IVF). IVM preceded by a prematuration step improves the acquisition of oocyte developmental competence and can enhance embryo quality (EQ). This study evaluated the effectiveness of a biphasic culture system incorporating prematuration and IVM steps (CAPA-IVM) versus standard IVM in women with polycystic ovarian morphology (PCOM). Methods: Eighty women (age < 38 years, ≥ 25 follicles of 2–9 mm in both ovaries, no major uterine abnormalities) were randomized to undergo CAPA-IVM (n = 40) or standard IVM (n = 40). CAPA-IVM uses two steps: a 24-h prematuration step with C-type natriuretic peptide-supplemented medium, then 30 h of culture in IVM media supplemented with follicle-stimulating hormone and amphiregulin. Standard IVM was performed using routine protocols. Results: A significantly higher proportion of oocytes reached metaphase II at 30 h after CAPA-IVM versus standard IVM (63.6 vs 49.0; p < 0.001) and the number of good quality embryos per cumulus-oocyte complex tended to be higher (18.9 vs 12.7; p = 0.11). Clinical pregnancy rate per embryo transfer was 63.2% in the CAPA-IVM versus 38.5% in the standard IVM group (p = 0.04). Live birth rate per embryo transfer was not statistically different between the CAPA-IVM and standard IVM groups (50.0 vs 33.3% [p = 0.17]). No malformations were reported and birth weight was similar in the two treatment groups. Conclusions: Use of the CAPA-IVM system significantly improved maturation and clinical pregnancy rates versus standard IVM in patients with PCOM. Furthermore, live births after CAPA-IVM are reported for the first time. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Springer |
|
dc.relation.ispartofseries |
Journal of Assisted Reproduction and Genetics |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
In vitro fertilization |
en_US |
dc.subject |
In vitro maturation |
en_US |
dc.subject |
Polycystic ovary syndrome |
en_US |
dc.subject |
Oocyte prematuration |
en_US |
dc.subject |
C-type natriuretic peptide |
en_US |
dc.title |
Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1007/s10815-019-01677-6 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.02 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.02 |
|
dc.relation.issn |
1573-7330 |
|